<DOC>
	<DOCNO>NCT01176227</DOCNO>
	<brief_summary>The Canadian College Naturopathic Medicine conduct research study Irritable Bowel Syndrome ( IBS ) , common condition North America . It long term , recur gastrointestinal disorder estimate affect 30 % general population . IBS characterize abdominal pain cramp , bowel dysfunction diarrhea bloating . The medicine currently use help people IBS effective would like . These medicine usually prescribe reduce pain IBS actually treat disorder . Recently , scientist find probiotic ( beneficial bacteria live inside human ) may help reduce painful symptom diarrhea part IBS . This research conduct determine whether particular combination three probiotic bacteria ( name Lactobacillus gasseri , Bifidobacterium bifidum Bifidobacterium longum ) reduce symptom IBS .</brief_summary>
	<brief_title>Efficacy Multi-strain Probiotic Treatment Irritable Bowel Syndrome ( IBS )</brief_title>
	<detailed_description>The purpose trial investigate effect three strain probiotic , Kyo-Dophilus , symptom associate Irritable Bowel Syndrome . The primary objective trial determine effectiveness Kyo-Dophilus symptom associate Irritable Bowel Syndrome adult population diagnose Irritable Bowel Syndrome ROME III criterion classify mild Irritable Bowel Severity Scoring System measure quality life global well patient Visual Analog Scale Irritable Bowel Syndrome-Quality Life Questioner . The secondary objective ass tolerability treatment use study diary .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Colonic Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Colonic Diseases , Functional</mesh_term>
	<criteria>Male female subject age 1864 A diagnosis Irritable Bowel Syndrome per ROME III criteria A classification mild irritable bowel syndrome indicate Irritable Bowel Severity Scoring System ( score &gt; 75 ) Female subject currently use acceptable form birth control agree maintain use throughout study ( e.g . abstinence , oral contraceptive , barrier method ) Subjects agree maintain current eating habit throughout study Ability understand sign Informed Consent Form Female subject breastfeeding , pregnant , open become pregnant next three month Subjects currently receive medication treatment IBS symptom Subjects currently receive natural health product treatment IBS symptom eligible inclusion trial agree undergo two week washout period Subjects currently experience nausea , fever , vomit , bloody diarrhea severe abdominal pain Subjects immunecompromised ( e.g . AIDS , lymphoma , patient undergoing longterm corticosteroid treatment ) Subjects currently receive antibiotic therapy antibiotic therapy within previous month Subjects regularly consume probiotic containing product ( e.g . yogurt , etc . ) Subjects recently ( &lt; 3 month ) initiate dietary measure control IBS symptom Subjects history major complicate gastrointestinal surgery Subjects severe endometriosis Subjects malignant tumor subject undergo chemotherapy radiation therapy Subjects severe IBS require medication Subjects weight loss , anaemia , inflammatory bowel disease , celiac sprue , family history colorectal cancer Subjects exhibit indicate thought suicide currently past base patient screen interview investigator/clinician . Appropriate referral health care provider provide Subjects known allergy milk milk base product Subjects use and/or use antipsychotic anticholinergic medication within prior month , report significant abnormality thyroid function test , blood count serum chemistry Subjects 50 year old diagnose IBS receive colonoscopy last five year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>bloating</keyword>
	<keyword>constipation</keyword>
	<keyword>diarrhea</keyword>
	<keyword>gas</keyword>
	<keyword>mucous</keyword>
	<keyword>cramp</keyword>
</DOC>